Premarket Mover: InterCure Ltd (INCR) Down 1.22%

InterCure Ltd (INCR) is lower by Monday morning, with the stock losing -1.22% in pre-market trading to 1.62. INCR's short-term technical score of 1 indicates that the stock has traded less bullishly over the last month than 99% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 137 out of 146 industries, InterCure Ltd ranks higher than 3% of stocks. InterCure Ltd has fallen 23.00% over the past month, closing at $2.00 on June 19. During this period of time, the stock fell as low as $1.57 and as high as $2.06. INCR has an average analyst recommendation of Strong Buy. The company has an average price target of $5.00.

INCR has an Overall Score of 27. Find out what this means to you and get the rest of the rankings on INCR!

See Full INCR Report

InterCure Ltd has a Long-Term Technical rank of 3. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 97% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 138 by this metric, INCR ranks better than 138% of stocks.

Important Dates for Investors in INCR:

-InterCure Ltd is set to release earnings on 8/21/2023. Over the last 12 months, the company has reported EPS of $0.81. -We do not have a set dividend date for InterCure Ltd at this time. Click Here To Get The Full Report on InterCure Ltd (INCR)